XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Net Unrealized Appreciation (Depreciation) on Investments [Member]
Defined Benefit Pension and Postretirement Plans [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Member]
Treasury Stock [Member]
Balance at beginning of period at Dec. 31, 2020   $ 0.6 $ 1,857.4 $ 428.1 $ (55.6) $ 2,668.0    
Balance at beginning of period at Dec. 31, 2020               $ (1,696.3)
Net income $ 221.2         221.2    
Shares purchased at cost               (123.6)
Employee and director stock-based awards and other     16.0          
Net appreciation (depreciation) on available-for-sale securities (123.4)     (123.4)        
Net amount recognized as net periodic benefit         1.4      
Dividends to shareholders           (51.3)    
Net shares reissued at cost under employee stock-based compensation plans               11.5
Balance at end of period at Jun. 30, 2021 3,154.0   1,873.4 304.7 (54.2) 2,837.9 $ 250.5  
Balance at end of period at Jun. 30, 2021               (1,808.4)
Balance at beginning of period at Mar. 31, 2021   0.6 1,864.0 242.6 (54.9) 2,734.9    
Balance at beginning of period at Mar. 31, 2021               (1,740.4)
Net income 128.5         128.5    
Shares purchased at cost               (73.3)
Employee and director stock-based awards and other     9.4          
Net appreciation (depreciation) on available-for-sale securities 62.1     62.1        
Net amount recognized as net periodic benefit         0.7      
Dividends to shareholders           (25.5)    
Net shares reissued at cost under employee stock-based compensation plans               5.3
Balance at end of period at Jun. 30, 2021 3,154.0   1,873.4 304.7 (54.2) 2,837.9 250.5  
Balance at end of period at Jun. 30, 2021               (1,808.4)
Balance at beginning of period at Dec. 31, 2021 3,144.9 0.6 1,887.2 184.9 (62.7) 2,983.2    
Balance at beginning of period at Dec. 31, 2021 (1,848.3)             (1,848.3)
Net income 127.4         127.4    
Shares purchased at cost               (20.4)
Employee and director stock-based awards and other     9.6          
Net appreciation (depreciation) on available-for-sale securities (644.3)     (644.3)        
Net amount recognized as net periodic benefit         2.2      
Dividends to shareholders           (53.9)    
Net shares reissued at cost under employee stock-based compensation plans               6.3
Balance at end of period at Jun. 30, 2022 2,571.8   1,896.8 (459.4) (60.5) 3,056.7 (519.9)  
Balance at end of period at Jun. 30, 2022 (1,862.4)             (1,862.4)
Balance at beginning of period at Mar. 31, 2022   $ 0.6 1,887.8 (195.0) (61.6) 3,061.0    
Balance at beginning of period at Mar. 31, 2022               (1,860.0)
Net income 22.6         22.6    
Shares purchased at cost               (4.1)
Employee and director stock-based awards and other     9.0          
Net appreciation (depreciation) on available-for-sale securities (264.4)     (264.4)        
Net amount recognized as net periodic benefit         1.1      
Dividends to shareholders           (26.9)    
Net shares reissued at cost under employee stock-based compensation plans               1.7
Balance at end of period at Jun. 30, 2022 2,571.8   $ 1,896.8 $ (459.4) $ (60.5) $ 3,056.7 $ (519.9)  
Balance at end of period at Jun. 30, 2022 $ (1,862.4)             $ (1,862.4)